GO:0140639 positive regulation of pyroptotic inflammatory response: Inflammasome Activation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140639 describes any process that increases the frequency, rate or extent of a pyroptotic inflammatory response, a lytic form of programmed cell death that releases inflammatory cytokines and danger signals.
• The term is a biological_process child of the broader regulation of pyroptosis and is mechanistically driven by inflammasome sensors such as NLRP3, NLRP1, NLRC4, AIM2 and NLRP6, the adaptor ASC, caspase-1, and the pore-forming executioner gasdermin D.
• Positive regulation can occur at multiple nodes: inflammasome assembly, caspase-1 activation, gasdermin D cleavage and oligomerization, and cytokine maturation, making it a highly tunable signaling axis.
• Dysregulated positive regulation of pyroptosis contributes to acute lung injury, sepsis, depressive-like behaviors, photoreceptor degeneration, irreversible pulpitis, and influenza-associated immunopathology.
• Key experimental handles include Trim21-mediated gasdermin D oligomerization, SIRT1/Nrf2-dependent NLRP3 restraint, TREM2-dependent myeloid inflammasome suppression, and NLRP6-dependent negative regulation of host defense.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of each node in the pathway, while CRISPR library screening and bioinformatics can nominate new positive regulators.
Description
GO:0140639, positive regulation of pyroptotic inflammatory response, is a Gene Ontology biological_process term that captures any molecular event which increases the frequency, rate or extent of pyroptosis-associated inflammation. Pyroptosis is a lytic, caspase-dependent cell death that is classically initiated by inflammasome sensors and executed by gasdermin D, resulting in the release of interleukin-1 family cytokines and intracellular danger signals. Because this response sits at the intersection of innate immunity, tissue injury and chronic inflammation, understanding its positive regulation is central to immunology, infectious disease and inflammation research. Mechanistically, positive regulation of pyroptotic inflammatory response is not a single reaction but a network of checkpoints. Inflammasome sensors such as NLRP3, NLRP1, NLRC4, AIM2 and NLRP6 detect microbial or endogenous danger signals and nucleate ASC-dependent platforms that activate caspase-1. Active caspase-1 then cleaves gasdermin D to liberate its pore-forming N-terminal fragment, and it also matures pro-IL-1beta and pro-IL-18. Positive regulators can act by promoting sensor activation, accelerating ASC speck formation, enhancing caspase-1 activity, stabilizing gasdermin D oligomers, or removing brakes such as SIRT1/Nrf2 and TREM2. For researchers, GO:0140639 provides a standardized annotation axis for comparing genetic, pharmacological and microbial perturbations that amplify pyroptosis. Real PubMed literature links this term to acute lung injury, polymicrobial sepsis, influenza immunopathology, depressive-like behaviors, photoreceptor degeneration and irreversible pulpitis, making it a high-value target for CRISPR-based functional genomics.
positive regulation of pyroptotic inflammatory response At A Glance
| GO ID | GO:0140639 |
|---|---|
| GO term | positive regulation of pyroptotic inflammatory response |
| Ontology | biological_process |
| Synonym | positive regulation of pyroptosis |
| Definition | Any process that increases the frequency, rate or extent of a pyroptotic inflammatory response. |
| Major function | Amplification of inflammasome-dependent, gasdermin D-mediated lytic cell death and cytokine release. |
| Representative sensors | NLRP3, NLRP1, NLRC4, AIM2, NLRP6 |
| Representative effectors | Caspase-1, gasdermin D, IL-1beta, IL-18 |
| Representative regulators | TRIM21, SIRT1/Nrf2, TREM2 |
| Disease relevance | Acute lung injury, sepsis, influenza, depression-like behavior, photoreceptor degeneration, pulpitis |
What Is GO:0140639?
In our own words, GO:0140639 (positive regulation of pyroptotic inflammatory response) refers to any process that increases the frequency, rate or extent of a pyroptotic inflammatory response. It is a biological_process term whose synonym is positive regulation of pyroptosis. The term covers upstream signaling that amplifies inflammasome activation, caspase-1 activity, gasdermin D pore formation, and the consequent release of inflammatory mediators, without being restricted to a single gene product or cell type.
Why Is positive regulation of pyroptotic inflammatory response Important in Cell Biology?
GO:0140639 matters because positive regulation of pyroptotic inflammatory response determines whether innate immune sensing resolves an infection or escalates into tissue-damaging inflammation. In polymicrobial sepsis, NLRP6 acts as a negative regulator of host defense, illustrating that the balance of positive and negative regulation directly affects survival. In influenza, NLRP3 inflammasome activation contributes to immunopathology, so understanding positive regulators can identify host-directed therapeutic targets. In sterile inflammatory settings such as acute lung injury, depressive-like behaviors, photoreceptor degeneration and irreversible pulpitis, excessive pyroptosis amplification drives pathology, and interventions that restrain positive regulators are protective. Consequently, this GO term is a practical annotation hub for CRISPR screens, drug discovery and biomarker development.
• Defines a druggable checkpoint in innate immunity that controls IL-1beta and IL-18 release.
• Links microbial sensing to lytic cell death through gasdermin D pore formation.
• Explains immunopathology in influenza and bacterial sepsis, where excessive pyroptosis worsens outcomes.
• Provides mechanistic context for acute lung injury and neutrophil extracellular trap crosstalk.
• Connects neuroinflammation to depressive-like behaviors via microglial NLRP3 activation.
• Implicates TREM2-dependent myeloid restraint in protection against photoreceptor degeneration.
• Highlights NLRP1 as a pyroptosis biomarker in irreversible pulpitis.
• Supports CRISPR functional genomics to discover new positive and negative regulators.
• Enables cross-species comparison of inflammasome biology in infection and sterile inflammation.
• Offers a standardized GO annotation for reproducible meta-analysis of pyroptosis studies.
What Happens During positive regulation of pyroptotic inflammatory response?
Priming and sensor activation
In simple terms: First, the cell gets ready and its danger sensors switch on.
Positive regulation begins with priming signals that raise the abundance or activation state of inflammasome sensors such as NLRP3, NLRP1, NLRC4, AIM2 and NLRP6. In microglia, LPS-induced NLRP3 inflammasome activation is attenuated when the SIRT1/Nrf2 pathway is engaged, showing that priming is a regulated and reversible step. In bacterial infection models, inflammasome-dependent sensing is required to restrict bacterial replication, and positive regulators amplify this response. NLRP1 has been detected as a pyroptosis biomarker in irreversible pulpitis, indicating that sensor abundance can mark active positive regulation in human tissue.
Inflammasome assembly and caspase-1 activation
In simple terms: The sensors build a platform that switches on a molecular scissors called caspase-1.
Upon activation, sensors nucleate ASC-dependent inflammasome platforms that recruit and activate caspase-1. Positive regulation at this node increases the frequency or rate of platform assembly, thereby increasing caspase-1 activity. NLRP6 negatively regulates host defense against polymicrobial sepsis, demonstrating that the net output of this step is determined by competing positive and negative inputs. In influenza, NLRP3 inflammasome activation is a central mechanism of antiviral and immunopathological responses, and its positive regulation shapes disease severity.
Gasdermin D cleavage and oligomerization
In simple terms: Caspase-1 cuts gasdermin D so it can punch holes in the cell membrane.
Active caspase-1 cleaves gasdermin D to release an N-terminal pore-forming fragment, and positive regulation of this step increases membrane permeabilization and lytic death. TRIM21 promotes gasdermin D oligomerization and thereby regulates pyroptotic cell death, providing a direct example of a positive regulator acting at the executioner level. Because gasdermin D oligomerization is required for pore formation, factors that stabilize oligomers amplify the pyroptotic inflammatory response.
Cytokine maturation and release
In simple terms: The cell releases inflammatory alarm signals that recruit immune cells.
Caspase-1 also matures pro-IL-1beta and pro-IL-18, which are released through gasdermin D pores along with danger-associated molecular patterns. Positive regulation of pyroptotic inflammatory response therefore increases the extracellular concentration of these cytokines and amplifies immune cell recruitment. In acute lung injury, disrupting the macrophage pyroptosis-neutrophil extracellular trap axis ameliorates injury, showing that cytokine and pore-mediated release are functionally linked to tissue damage.
Brakes and negative feedback
In simple terms: There are built-in brakes that keep the response from running out of control.
Positive regulation is defined relative to negative regulators that restrain the pathway. TREM2 restrains myeloid inflammasome activation to protect against photoreceptor degeneration, illustrating a brake whose loss increases positive regulation. SIRT1/Nrf2 signaling attenuates microglial NLRP3 inflammasome activation, and NLRP6 negatively regulates host defense in sepsis. These examples show that the observed extent of positive regulation is the net result of activating and inhibitory inputs.
Key Genes Involved in GO:0140639 positive regulation of pyroptotic inflammatory response
The following genes and proteins are experimentally implicated in positive regulation of pyroptotic inflammatory response or in its negative restraint, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP3 | Inflammasome sensor that nucleates caspase-1 activation platforms | Central node in microglial and influenza-associated pyroptosis |
| NLRP1 | Inflammasome sensor detected as a pyroptosis biomarker | Biomarker and mechanistic target in irreversible pulpitis |
| NLRC4 | Inflammasome sensor for bacterial ligands | Innate sensing and restriction of bacterial replication |
| AIM2 | Cytosolic DNA-sensing inflammasome sensor | Inflammasome-dependent host defense |
| NLRP6 | Inflammasome sensor with negative regulatory roles in sepsis | Host defense balance in polymicrobial sepsis |
| PYCARD (ASC) | Adaptor that bridges sensors to caspase-1 | Inflammasome assembly and speck formation |
| CASP1 | Caspase-1 protease that cleaves gasdermin D and cytokines | Executioner of pyroptosis and cytokine maturation |
| GSDMD | Gasdermin D pore-forming executioner | Membrane permeabilization and lytic death |
| TRIM21 | E3 ligase that promotes gasdermin D oligomerization | Positive regulator of pyroptotic cell death |
| SIRT1 | Deacetylase linked to Nrf2-dependent NLRP3 restraint | Negative regulation of microglial inflammasome |
| NFE2L2 (Nrf2) | Transcription factor mediating antioxidant restraint of NLRP3 | Negative regulation of LPS-induced inflammasome activation |
| TREM2 | Myeloid receptor that restrains inflammasome activation | Protection against photoreceptor degeneration |
| IL1B | Pro-inflammatory cytokine matured by caspase-1 | Readout of pyroptotic inflammatory response |
| IL18 | Pro-inflammatory cytokine matured by caspase-1 | Readout of pyroptotic inflammatory response |
| GSDMD-NT | N-terminal gasdermin D fragment that forms membrane pores | Direct effector of lytic cell death |
| Cordyceps sinensis polysaccharide target axis | Disrupts macrophage pyroptosis-neutrophil extracellular trap axis | Pharmacological modulation in acute lung injury |
How Is positive regulation of pyroptotic inflammatory response Regulated?
Positive regulation of pyroptotic inflammatory response is controlled by layered positive and negative inputs. SIRT1/Nrf2 signaling attenuates LPS-induced microglial NLRP3 inflammasome activation, indicating that antioxidant and deacetylase pathways act as brakes. TRIM21 promotes gasdermin D oligomerization, providing a direct positive regulatory mechanism at the executioner step. NLRP6 negatively regulates host defense against polymicrobial sepsis, showing that sensor-level regulation can be inhibitory in specific contexts. TREM2 restrains myeloid inflammasome activation and protects against photoreceptor degeneration, adding a receptor-mediated brake. In acute lung injury, Cordyceps sinensis polysaccharide disrupts the macrophage pyroptosis-neutrophil extracellular trap axis, demonstrating pharmacological modulation of the pathway. Together, these studies show that the term is regulated by competing activating and inhibitory signals rather than by a single upstream switch.
positive regulation of pyroptotic inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Depressive-like behaviors and microglial inflammation | LPS-treated microglial cell line with SIRT1/Nrf2 modulation |
| NLRP6 | Polymicrobial sepsis and host defense | Cecal ligation and puncture sepsis model with Nlrp6 knockout |
| GSDMD | Pyroptotic cell death and membrane permeabilization | Trim21 knockout or overexpression cells with gasdermin D oligomerization assays |
| TREM2 | Photoreceptor degeneration | Trem2 knockout myeloid cells or retinal degeneration models |
| NLRP1 | Irreversible pulpitis | Human dental pulp tissue and animal pulpitis models |
Infection and sepsis
In polymicrobial sepsis, NLRP6 negatively regulates host defense, and loss of this restraint alters the balance of pyroptotic inflammatory response and survival. In bacterial infection, inflammasome-dependent mechanisms sense and restrict bacterial replication, so positive regulation is protective when appropriately controlled. In influenza, NLRP3 inflammasome activation contributes to both antiviral defense and immunopathology, making positive regulation a double-edged sword.
Acute lung injury and neutrophilic inflammation
Cordyceps sinensis polysaccharide disrupts the macrophage pyroptosis-neutrophil extracellular trap axis to ameliorate acute lung injury, directly linking positive regulation of pyroptosis to lung tissue damage. This suggests that pharmacological or genetic reduction of positive regulation can be therapeutic in acute inflammatory lung disease.
Neuroinflammation and degeneration
LPS-induced acute depressive-like behaviors are accompanied by microglial NLRP3 inflammasome activation, which is attenuated through the SIRT1/Nrf2 pathway. TREM2 restrains myeloid inflammasome activation to protect against photoreceptor degeneration, showing that positive regulation of pyroptosis contributes to retinal neurodegeneration when brakes fail.
Dental and oral inflammation
NLRP1 has been proposed as a novel pyroptosis biomarker in irreversible pulpitis, linking positive regulation of pyroptotic inflammatory response to dental pulp inflammation and providing a candidate diagnostic and therapeutic target.
From positive regulation of pyroptotic inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for positive regulation of pyroptosis? | CRISPR knockout in macrophages or epithelial cells followed by inflammasome stimulation |
| Does a specific phosphorylation or cleavage site control gasdermin D activity? | Point-mutation knock-in of GSDMD at the candidate residue |
| Does a disease-associated variant increase pyroptosis? | Knock-in of the variant allele and measurement of caspase-1 and IL-1beta |
| Where does a regulator localize during inflammasome assembly? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a sensor amplify pyroptotic inflammatory response? | Doxycycline-inducible overexpression of NLRP3, NLRP1 or NLRC4 |
| Which genes modify pyroptosis in a genome-wide manner? | CRISPR library screening with pyroptosis-dependent selection |
How to Study the positive regulation of pyroptotic inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Caspase-1 activity assay | Enzymatic activation of caspase-1 | Confirming inflammasome activation after priming |
| IL-1beta ELISA | Mature cytokine release | Quantifying pyroptotic inflammatory output |
| Gasdermin D Western blot | N-terminal cleavage fragment | Assessing executioner activation |
| Oligomerization cross-linking | Gasdermin D oligomer formation | Testing TRIM21-dependent positive regulation |
| LDH release assay | Membrane permeabilization | Measuring lytic cell death |
| RNA-seq | Transcriptional signatures of inflammasome genes | Biomarker discovery in pulpitis and other tissues |
| CRISPR knockout screening | Genes required for pyroptosis | Genome-wide discovery of positive regulators |
| Live-cell imaging | ASC speck and pore dynamics | Visualizing assembly and execution steps |
Inflammasome activation assays
Measuring caspase-1 activation, ASC speck formation and IL-1beta release after LPS priming and ATP or nigericin stimulation is the standard way to quantify positive regulation of pyroptotic inflammatory response. These assays can be combined with SIRT1/Nrf2 or TREM2 perturbation to test negative regulation.
Gasdermin D cleavage and oligomerization
Western blotting for gasdermin D N-terminal fragment and cross-linking or native gel analysis of oligomers directly reports executioner activation, as demonstrated for TRIM21-dependent oligomerization. This is essential because gasdermin D pore formation is the committed step of pyroptosis.
Cytotoxicity and pore-formation readouts
LDH release, propidium iodide uptake and live-cell imaging measure membrane permeabilization downstream of gasdermin D. In acute lung injury models, these readouts can be paired with neutrophil extracellular trap quantification to capture the pyroptosis-NET axis.
Transcriptomics and biomarker analysis
RNA-seq and targeted expression analysis of NLRP1, NLRP3, GSDMD and IL1B can identify positive regulation signatures in patient tissue, as shown for NLRP1 in irreversible pulpitis. Such data can be integrated with CRISPR screening hits to prioritize causal regulators.
How CRISPR Can Be Used to Study GO:0140639 positive regulation of pyroptotic inflammatory response
Knockout
CRISPR knockout of candidate positive regulators such as Trim21, Nlrp3, Nlrp6, Gsdmd or Trem2 allows causal testing of whether a gene is required for positive regulation of pyroptotic inflammatory response. Knockout of negative regulators such as SIRT1/Nrf2 components is expected to enhance the response, providing a bidirectional test.
Point Mutation
Point-mutation knock-in can dissect specific residues in gasdermin D or inflammasome sensors that are required for oligomerization, cleavage or signaling. This approach is especially valuable when a disease-associated variant is suspected to alter pyroptosis amplitude.
Knock-in
Tagged knock-in of NLRP3, ASC, caspase-1 or gasdermin D enables real-time tracking of inflammasome assembly and pore formation in live cells. Knock-in of reporter cassettes under endogenous promoters can also provide physiological expression levels for screening.
Overexpression
Overexpression of sensors such as NLRP1, NLRP3 or NLRC4 can amplify pyroptotic inflammatory response and sensitize cells to stimulation, which is useful for gain-of-function studies and for building robust assay platforms. Inducible overexpression avoids confounding effects of chronic inflammasome activation.
How EDITGENE Supports positive regulation of pyroptotic inflammatory response Research
Researchers studying positive regulation of pyroptotic inflammatory response-related genes often need to determine whether a candidate gene is causally involved in inflammasome activation, gasdermin D execution or cytokine release, rather than merely correlated with it. EDITGENE provides the CRISPR and bioinformatics toolkit to move from candidate lists to validated mechanisms.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of pyroptotic inflammatory response research.
Frequently Asked Questions About positive regulation of pyroptotic inflammatory response
What is GO:0140639 positive regulation of pyroptotic inflammatory response?
It is a Gene Ontology biological_process term defined as any process that increases the frequency, rate or extent of a pyroptotic inflammatory response, with the synonym positive regulation of pyroptosis.
What genes are involved in positive regulation of pyroptotic inflammatory response?
Key genes include NLRP3, NLRP1, NLRC4, AIM2, NLRP6, PYCARD (ASC), CASP1, GSDMD, TRIM21, SIRT1, NFE2L2 (Nrf2), TREM2, IL1B and IL18.
How is pyroptosis positively regulated?
Positive regulation occurs through enhanced inflammasome assembly, caspase-1 activation, gasdermin D cleavage and oligomerization, and cytokine maturation, as shown for TRIM21-dependent gasdermin D oligomerization.
What is the role of gasdermin D in pyroptotic inflammatory response?
Gasdermin D is cleaved by caspase-1 to release an N-terminal pore-forming fragment that permeabilizes the membrane and drives lytic death and cytokine release.
Which diseases are linked to positive regulation of pyroptosis?
Published studies link it to polymicrobial sepsis, influenza immunopathology, acute lung injury, depressive-like behaviors, photoreceptor degeneration and irreversible pulpitis.
How can CRISPR be used to study GO:0140639?
CRISPR knockout, point mutation, knock-in and overexpression models can test whether specific genes are required for or sufficient to amplify pyroptotic inflammatory response.
What is the difference between pyroptosis and apoptosis?
Pyroptosis is a lytic, inflammasome- and gasdermin D-dependent inflammatory cell death, whereas apoptosis is generally non-lytic and immunologically silent.
What are the best experimental readouts for pyroptotic inflammatory response?
Common readouts include caspase-1 activity, IL-1beta ELISA, gasdermin D cleavage and oligomerization, LDH release and live-cell imaging of ASC specks.
Does TREM2 regulate pyroptosis?
Yes, TREM2 restrains myeloid inflammasome activation and protects against photoreceptor degeneration, acting as a brake on positive regulation.
Is NLRP1 a biomarker for pulpitis?
NLRP1 has been reported as a novel pyroptosis biomarker in irreversible pulpitis in a laboratory and animal model study.
Conclusion
GO:0140639 positive regulation of pyroptotic inflammatory response is a mechanistically rich biological_process term that integrates inflammasome sensing, caspase-1 activation, gasdermin D execution and cytokine release. Real PubMed evidence shows that this pathway is amplified by factors such as TRIM21 and restrained by SIRT1/Nrf2, TREM2 and NLRP6, with disease relevance spanning sepsis, influenza, acute lung injury, neuroinflammation and pulpitis. Because the pathway is genetically tractable, CRISPR knockout, point-mutation, knock-in, overexpression and library screening approaches can convert correlative observations into causal mechanisms. EDITGENE supports these workflows to accelerate discovery of therapeutic targets within GO:0140639.
References
- 1. Arioz BI et al.. 2019. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.. Front Immunol 10:1511 PMID: 31327964
- 2. Gao W et al.. 2022. TRIM21 regulates pyroptotic cell death by promoting Gasdermin D oligomerization.. Cell Death Differ 29(2):439-450 PMID: 34511601
- 3. Ghimire L et al.. 2024. NLRP6 negatively regulates host defense against polymicrobial sepsis.. Front Immunol 15:1248907 PMID: 38720893
- 4. Tate MD et al.. 2018. An update on the NLRP3 inflammasome and influenza: the road to redemption or perdition?. Curr Opin Immunol 54:80-85 PMID: 29986838
- 5. Xu J et al.. 2026. Cordyceps sinensis polysaccharide disrupts the macrophage pyroptosis-neutrophil extracellular traps axis to ameliorate acute lung injury.. J Ethnopharmacol 370:122063 PMID: 42302943
- 6. Wang T et al.. 2026. TREM2 restrains myeloid inflammasome activation to protect against photoreceptor degeneration.. J Neuroinflammation 23(1) PMID: 42288845
- 7. Andrade WA et al.. 2018. Inflammasome-dependent Mechanisms Involved in Sensing and Restriction of Bacterial Replication.. Curr Issues Mol Biol 25:99-132 PMID: 28875942
- 8. Wu J et al.. 2026. NLRP1 as a Novel Pyroptosis Biomarker in Irreversible Pulpitis: A Laboratory Investigation and Animal Model Study.. Int Endod J 59(4):643-655 PMID: 41400095
